Holen Sie sich die Stockscreener-App
40.66
3.88%
1.52
Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
78.52%
10.29
|
47.88 | 4.728 | 16.51 | 9.466 |
Operating Expenses
|
1.37%
68.12
|
67.20 | 62.24 | 59.90 | 54.79 |
| Benefits Costs and Expenses |
73.91%
58.84
|
225.55 | - | - | 50.39 |
| Costs And Expenses |
21.01%
58.84
|
48.63 | 62.24 | 59.90 | 50.39 |
| Operating Income/Loss |
199.46%
-57.83
|
-19.31 | -57.51 | -43.38 | -45.33 |
| Income/Loss From Continuing Operations Before Tax |
72.67%
-48.56
|
-177.67 | 4.728 | 16.51 | -40.93 |
| Income/Loss From Continuing Operations After Tax |
237.95%
-48.56
|
-14.37 | -52.87 | -38.80 | -40.93 |
|
Net Income/Loss
|
237.95%
-48.56
|
-14.37 | -52.87 | -38.80 | -40.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
134.22K%
70.77
|
0.0527 | 58.42 | 58.33 | 58.19 |
| Diluted Average Shares |
134.22K%
70.77
|
0.0527 | 58.42 | 58.33 | 58.19 |
| Basic Earnings Per Share |
176.00%
-0.69
|
-0.25 | -0.90 | -0.67 | -0.70 |
| Diluted Earnings Per Share |
176.00%
-0.69
|
-0.25 | -0.90 | -0.67 | -0.70 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):